undamentalytics Newsletter

Praxis Precision Medicines, Inc. valuation and forecast

Explore the models for Praxis Precision Medicines, Inc., adjust their assumptions and compare your own valuation with the platform's.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: every model's value for Praxis Precision Medicines, Inc. is far from the share price, which usually points to a data problem (a merger, a share-count change, a one-off) rather than a bargain or a bubble.

Price vs value

Under review: limited reported history: available models are shown without a Buy/Hold/Sell rating. We'll show the comparison once resolved.

Analyst recommendations

21 analysts, Oct 2026
Buy1990%
Hold15%
Sell15%

Monthly trend

  1. Oct 202641521
  2. Sep 202631419
  3. Aug 202631419
  4. Jul 202631419

Counts of recommendations published by analysts covering Praxis Precision Medicines, Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Price history

Loading chart…

Third-party market data · may be delayed

PRAX valuation questions

How does Fundamentalytics value Praxis Precision Medicines, Inc.?
We use the models that fit Praxis Precision Medicines, Inc.'s business and available financial data. Each model has its own assumptions and data requirements. The calculator explains which models are available and lets you adjust their inputs.

Data: SEC EDGAR filings, retrieved Invalid Date. Method: how we value companies. Disclosures: research and recommendations disclosure. Back to Praxis Precision Medicines, Inc.